DTC pharma marketing is rapidly evolving from an advertising function into a patient-access and experience function. Generative AI, telehealth, e-commerce, streaming media, and changing patient expectations mean DTC teams increasingly need to build a seamless “front door” that helps patients move from information and disease education to treatment and access. To bring non-DTC colleagues along, marketers should stop framing DTC primarily around campaigns and awareness and instead demonstrate its value to Market Access, Legal/Regulatory, HCP Marketing, Sales, and Finance through patient behavior and measurable outcomes. Here are some guidelines…
You probably feel like your head is spinning working in Direct-to-Consumer (DTC) Marketing right now. We’ve moved from running traditional linear television campaigns to building bridges that help patients access our products through DTP Telehealth programs. Generative AI has changed how patients search for information online. Patients want their front door to look like the one they use at their bank.
If you reach outside your function, your non-DTC Manager may be behind on what’s happening with DTC marketing. Many think DTC is all about getting Awareness through expensive media placements and creating 30-second television commercials.
Here are a few ways to bridge the gap with your non-DTC counterparts.
1ne. Don’t Tell Them About Advertising
When your non-DTC counterparts hear that you’re working on a campaign or advertising, they may start to tune out. Make sure your message makes it clear that we aren’t advertising; we are building infrastructure for our patients.
- Tell them that DTC marketing helps bridge the gap between patients and their treatment. Its no longer just about awareness; we’re helping create a seamless front door experience.
- Help them see how you can lead into your DTC campaign by bridging to Telehealth or offering e-commerce options. Once they understand that your DTC Campaign can help drive to Telehealth, your Market Access and Sales counterparts will understand the value.
2wo. Educate Your Market Access Team
Market Access managers deal with where our drugs sit on Formularies. Show them how DTC can impact Market Access by educating them on patients’ online behavior.
- Tell them we’ve seen an increase in patients searching online for how to access our product. We need to make sure our Front Door provides patients with up-to-date information on how to access our product.
- Provide data to show your Market Access team how many patients we are losing because our Front Door isn’t user-friendly. By involving them in the process, we can ensure we create experiences aligned with patients’ needs.
3hree. Tell Regulatory and Legal Why We’re Doing What We’re Doing
Often, when regulatory and legal teams hear about DTC innovation, they immediately think about how it could create problems for our company. Help them understand why its important to stay on top of these changes.
- Patients are using AI and Online Forums to find answers to their questions. We want to provide the correct answers to our patients.
- Help them understand that by creating these online presences, we create an environment for patients to learn about our brands. This can help streamline approvals for your DTC campaigns.
4our. Break down the HCP Silo
Surveys show that although companies believe in breaking down the silo between HCP and DTC. budgets still reflect a division between the two. Your non-DTC counterpart in HCP Marketing may not know that the patients they’re talking to are informed through digital channels.
- Let them know that our patients are becoming more informed on how to manage their disease online.
- By providing data to your non-DTC colleagues, they will begin to understand the benefits of providing a seamless front door experience to our patients.
But What About TV?
Bringing up traditional TV commercials is the fastest way to get non-DTC managers—especially finance, legal, and Market Access—to roll their eyes. To them, a $5 million national broadcast spot looks like an expensive, blunt instrument that shouts a message into the void while dodging precise measurement. And increasingly, the data proves they’re right.
When talking to your enterprise peers, acknowledging that linear TV ads are often a massive financial sinkhole can actually build immediate credibility. Here is how to frame the conversation around why the traditional TV playbook is losing steam—and where those dollars should go instead.
1ne. The ROI is Collapsing Under Market Saturation
For years, the logic of a blockbuster TV campaign was simple: buy millions of eyeballs, drive massive awareness, and watch prescriptions tick up. Today, that math is broken.
- The Reality: The airwaves are profoundly overcrowded. With dozens of brands competing in hyper-crowded categories (like immunology or diabetes), linear TV ad spending has surged into the billions, yet the overall return on investment (ROI) at launch has steadily declined.IQVIA
- How to frame it to Finance: Tell your finance colleagues that linear TV behaves like a diminishing-returns trap. Pouring massive sums into broad-stroke TV spots no longer guarantees a predictable lift in patient volume because audience attention is fractured and the airwaves are deafeningly loud.
2wo. You’re Paying to Reach People Who Can’t Even Get the Drug
Linear TV is the ultimate broad-brush medium—you buy demographics, not intent. This creates a massive fracture with Market Access.
- The Reality: A national TV spot broadcasts an expensive specialty drug to millions of households, many of whom either don’t have the clinical indication or face strict formulary exclusions and prior authorization walls.
- How to frame it to Market Access: Point out that traditional TV drives unqualifying demand. It prompts patients to ask their doctors for a medication they saw on TV, only for the prescription to be blocked at the pharmacy counter because of access hurdles or out-of-pocket costs. That mismatch creates administrative chaos for physicians and high abandonment rates for the brand.
3hree. Audiences Have Left Linear TV (Even if Pharma Budgets Haven’t)
Media consumption habits have fundamentally evolved, yet pharma marketing budgets have historically been slow to untether from legacy habits.
- The Reality: Viewers are ditching linear television for streaming platforms, Connected TV (CTV), and digital ecosystems. While billions are still poured into traditional broadcast slots, household impressions aren’t scaling at the same rate because the eyeballs simply aren’t parked in front of traditional cable the way they used to be.
- How to frame it to Brand Leads: Frame the shift away from linear TV not as cutting budget, but as reallocating waste. Moving dollars from blunt-instrument TV ads into targeted digital, CTV, and contextual search environments allows for precision targeting, real-time adjustments, and clear behavioral attribution that TV simply cannot match.
When non-DTC managers argue that TV ads are a waste of money, they are often reacting to an outdated 20th-century model of pharma marketing. Agreeing with them opens the door to a much smarter conversation: shifting from broadcasting noise to building pathways.
When you replace a legacy TV budget with an ecosystem of connected, measurable digital touchpoints, you stop paying for passive eyeballs and start investing in active patient journeys.
